The landscape of dementia prognosis has evolved significantly with the advent of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-centered assessments that could detect Alzheimer's pathology a long time ahead of indications emerge. Even though these technological advancements characterize outstanding development in understanding neurodegenerative illnesses, ... https://robertq924osv1.wiki-cms.com/user